Cambridge, Massachusetts-based ElevateBio, a biotech holding company, has secured $150 million in Series A financing. The investors included UBS Oncology Impact Fund, EcoR1 Capital, Redmile Group and Samsara BioCapital.
Source: Press Release
Cambridge, Massachusetts-based ElevateBio, a biotech holding company, has secured $150 million in Series A financing. The investors included UBS Oncology Impact Fund, EcoR1 Capital, Redmile Group and Samsara BioCapital.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: